CRVO Price / Book | CervoMed Inc.

CervoMed Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

CervoMed Inc. price/book ratio for the quarter ending 2026-06-30 was 1.83, a 5.02% increase year-over-year.
CervoMed Inc. price/book ratio for the quarter ending 2026-03-31 was 3.47, a 50.98% increase year-over-year.
CervoMed Inc. price/book ratio for the quarter ending 2025-12-31 was 4, a 669.25% increase year-over-year.
CervoMed Inc. price/book ratio for the quarter ending 2025-09-30 was 2.87, a 8.72% increase year-over-year.
CervoMed Inc. price/book ratio for fiscal 2026 was 1.83.
CervoMed Inc. price/book ratio for fiscal 2025 was 4, a 669.25% increase from fiscal 2024.
CervoMed Inc. price/book ratio for fiscal 2024 was 0.52, a 91.15% decline from fiscal 2023.
CervoMed Inc. price/book ratio for fiscal 2023 was 5.87, a change of 5.99 from fiscal 2022.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	1.83	$42.07M	$22.96M
2026-03-31	3.47	$36.85M	$10.62M
2025-12-31	4	$72.82M	$18.22M
2025-09-30	2.87	$74.67M	$26.01M
2025-06-30	1.74	$58.34M	$33.44M
2025-03-31	2.3	$79.63M	$34.63M
2024-12-31	0.52	$20.36M	$39.2M
2024-09-30	2.64	$120.5M	$45.64M
2024-06-30	2.83	$141.3M	$49.98M
2024-03-31	26.94	$143.77M	$5.34M
2023-12-31	5.87	$43.3M	$7.38M
2023-09-30	2.74	$26.22M	$9.57M
2023-06-30	-0.29	$10.22M	-$35.11M
2023-03-31	-0.38	$12.7M	-$33.75M
2022-12-31	-0.12	$3.93M	-$33.29M
2022-09-30	0.68	$16.36M	$24.05M
2022-06-30	0.77	$20.43M	$26.67M
2022-03-31	1.25	$38.22M	$30.62M
2021-12-31	1.36	$47.39M	$34.91M
2021-09-30	102.22	$3.9B	$38.13M
2021-06-30	111.21	$5.58B	$50.17M
2021-03-31	131.07	$7.03B	$53.65M
2020-12-31	154.79	$3.84B	$24.81M
2020-09-30	140.4	$4.03B	$28.72M
2020-06-30	143.08	$4.7B	$32.88M
2020-03-31	46.39	$830.51M	$17.9M
2019-12-31	57.37	$1.16B	$20.13M
2019-09-30	48.17	$651.19M	$13.52M
2019-06-30	62.01	$1B	$16.18M
2019-03-31	72.52	$939.44M	$12.95M
2018-12-31	32.28	$503.9M	$15.61M
2018-09-30	1,170.1	$24.46B	$20.91M
2018-06-30	958.64	$26.17B	$27.3M
2018-03-31	1,051.91	$31.26B	$29.72M
2017-12-31	60.53	$1.28B	$21.23M
2017-09-30	4,261.05	$27.09B	$6.36M
2017-06-30	27,494.29	$32.11B	$1.17M
2017-03-31	-2,429	$46.44B	-$19.12M
2016-12-31	2,863.87	$26.3B	$9.18M
2016-09-30	7,092.95	$81.47B	$11.49M
2016-06-30	66,351.74	$931.08B	$14.03M
2016-03-31	76,457.32	$1.27T	$16.58M
2015-12-31	-2,194,413.28	$91.34B	-$41,623.00
2014-12-31	18,107.41	$691.08B	$38.17M
2014-09-30	17,268.24	$739.07B	$42.8M
2014-06-30	19,092.68	$864.85B	$45.3M
2014-03-31	47,971.35	$586.16B	$12.22M
2013-12-31	30,379.72	$196.22B	$6.46M
2013-09-30	-8,283,407.54	$52.09T	-$6.29M
2013-06-30	-1,759,720.78	$15.03T	-$8.54M
2013-03-31	-774,563.51	$15.27T	-$19.71M
2012-12-31	-10,355.89	$190.42B	-$18.39M
2012-09-30	-7,075,670.95	$42.67T	-$6.03M
2012-06-30	-7,623,036.86	$38.68T	-$5.07M
2011-12-31	-3,087,253.37	$49.59T	-$16.06M
2011-09-30	11,097,277.04	$56.06T	$5.05M
2011-06-30	5,847,412.97	$50.6T	$8.65M
2010-12-31	2,282,947,966.18	$46.17T	$20,223.00

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	1.83	$42.07M	$22.96M
2025-12-31	4	$72.82M	$18.22M
2024-12-31	0.52	$20.36M	$39.2M
2023-12-31	5.87	$43.3M	$7.38M
2022-12-31	-0.12	$3.93M	-$33.29M
2021-12-31	1.36	$47.39M	$34.91M
2020-12-31	154.79	$3.84B	$24.81M
2019-12-31	57.37	$1.16B	$20.13M
2018-12-31	32.28	$503.9M	$15.61M
2017-12-31	60.53	$1.28B	$21.23M
2016-12-31	2,863.87	$26.3B	$9.18M
2015-12-31	-2,194,413.28	$91.34B	-$41,623.00
2014-12-31	18,107.41	$691.08B	$38.17M
2013-12-31	30,379.72	$196.22B	$6.46M
2012-12-31	-10,355.89	$190.42B	-$18.39M
2011-12-31	-3,087,253.37	$49.59T	-$16.06M
2010-12-31	2,282,947,966.18	$46.17T	$20,223.00

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Celularity Inc (CELU)	United States	$0.038B	-0.34
Edesa Biotech, Inc. (EDSA)	Canada	$0.039B
Actinium Pharmaceuticals, Inc. (ATNM)	United States	$0.038B	2.73
FILANA THERAPEUTICS, INC. (FLNA)	United States	$0.038B	-1.05
PMGC Holdings Inc. (ELAB)	United States	$0.037B
Karyopharm Therapeutics Inc. (KPTI)	United States	$0.039B	-0.98
BriaCell Therapeutics Corp. (BCTX)		$0.037B
Seres Therapeutics, Inc. (MCRB)	United States	$0.036B	-3.45
Incannex Healthcare Inc. (IXHL)		$0.040B	-22.32
MIRA PHARMACEUTICALS, INC. (MIRA)	United States	$0.036B	-4.30